These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8536551)
1. Drug management of noninfective complications of cystic fibrosis. Sanchez I; Guiraldes E Drugs; 1995 Oct; 50(4):626-35. PubMed ID: 8536551 [TBL] [Abstract][Full Text] [Related]
2. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report. Walicka-Serzysko K; Sands D Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072 [TBL] [Abstract][Full Text] [Related]
3. Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis. Bryson HM; Sorkin EM Drugs; 1994 Dec; 48(6):894-906. PubMed ID: 7533697 [TBL] [Abstract][Full Text] [Related]
5. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis. Hodson ME Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698 [TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis--an Indian perspective on recent advances in diagnosis and management. Kabra SK; Kabra M; Ghosh M; Verma IC Indian J Pediatr; 1996; 63(2):189-98. PubMed ID: 10829988 [TBL] [Abstract][Full Text] [Related]
7. Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis. Goa KL; Lamb H Pharmacoeconomics; 1997 Sep; 12(3):409-22. PubMed ID: 10170464 [TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis in adolescents and adults. The coming of age of cystic fibrosis. Mulherin D; FitzGerald M Dig Dis; 1992; 10(1):29-37. PubMed ID: 1551244 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary complications of cystic fibrosis. Flume PA Respir Care; 2009 May; 54(5):618-27. PubMed ID: 19393106 [TBL] [Abstract][Full Text] [Related]
10. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW; J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506 [TBL] [Abstract][Full Text] [Related]
11. Dornase alfa: a new option in the management of cystic fibrosis. Witt DM; Anderson L Pharmacotherapy; 1996; 16(1):40-8. PubMed ID: 8700791 [TBL] [Abstract][Full Text] [Related]
13. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease. Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165 [TBL] [Abstract][Full Text] [Related]
14. Bacteriology and treatment of infections in the upper and lower airways in patients with primary ciliary dyskinesia: adressing the paranasal sinuses. Alanin MC Dan Med J; 2017 May; 64(5):. PubMed ID: 28552099 [TBL] [Abstract][Full Text] [Related]
18. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Greally P; Whitaker P; Peckham D Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602 [TBL] [Abstract][Full Text] [Related]